These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4855735)

  • 21. Immunological evaluation in patients with urological cancers.
    Martinez-Piñeiro JA; Muntanola P; Hidalgo L
    Eur Urol; 1977; 3(3):159-62. PubMed ID: 560302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune evaluation with skin testing. A study of testicular, prostatic, and bladder neoplasms.
    Schellhammer PF; Bracken RB; Bean MA; Pinsky CM; Whitmore WF
    Cancer; 1976 Jul; 38(1):149-56. PubMed ID: 947511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irradiation and/or surgery. Some areas of confrontation in urologic oncology.
    Whitmore WF
    Am J Clin Oncol; 1984 Dec; 7(6):595-606. PubMed ID: 6099052
    [No Abstract]   [Full Text] [Related]  

  • 25. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors.
    Mostofi FK; Sesterhenn I
    Natl Cancer Inst Monogr; 1978 Dec; (49):133-41. PubMed ID: 571042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy for genitourinary cancer.
    Messing E; deKernion JB
    Surg Clin North Am; 1981 Dec; 61(6):1331-46. PubMed ID: 7198295
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunotherapy in genitourinary neoplasia.
    Droller MJ
    J Urol; 1985 Jan; 133(1):1-5. PubMed ID: 2578065
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro cytotoxicity studies in bladder and renal cell cancer.
    Elhilali MM; Nayak SK
    Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic competence in patients with urologic cancer.
    McLaughlin AP; Kessler WO; Triman K; Gittes RF
    J Urol; 1974 Feb; 111(2):233-7. PubMed ID: 4272638
    [No Abstract]   [Full Text] [Related]  

  • 30. Defective monocyte function in patients with genitourinary carcinoma.
    Hausman MS; Brosman S; Snyderman R; Mickey MR; Fahey J
    J Natl Cancer Inst; 1975 Nov; 55(5):1047-54. PubMed ID: 1107568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH
    Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response in bladder cancer.
    Merrin C; Han T
    J Urol; 1974 Feb; 111(2):170-2. PubMed ID: 4810757
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell-mediated cytotoxicity against human bladder cancer.
    Bloom ET; Ossorio RC; Brosman SA
    Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of alpha-globulin as a biological tracer in urogenital cancer].
    Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
    Actas Urol Esp; 1978; 2(3):119-26. PubMed ID: 79304
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    J Urol; 1974 Feb; 111(2):173-6. PubMed ID: 4810758
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular immunity in bladder cancer patients.
    Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
    J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective monocyte chemotactic response in genitourinary carcinoma.
    Brosman S; Hausman MS
    Urology; 1974 Aug; 4(2):129-34. PubMed ID: 4851277
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K; Yonese Y; Nakagami Y; Minowa T; Hiraoka Y; Yamada N; Hikima N; Ishii Y; Tannowa K; Fujioka Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.